Cannon Financial Strategists, Inc. Johnson & Johnson Transaction History

Cannon Financial Strategists, Inc.

$572 Billion
Q3 2024

A detailed history of Cannon Financial Strategists, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Cannon Financial Strategists, Inc. holds 2,523 shares of JNJ stock, worth $392,250. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,523

Previous 2,334 8.1%

Holding current value

$392,250

Previous $366 Million 11.77%

% of portfolio

0.07%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$145.48 - $167.38 $27,495 - $31,634	189 Added 8.1%	2,523 $409 Million
Q2 2024 Sep 10, 2024	BUY	$144.38 - $157.78 $384,195 - $419,852	2,661 New	2,661 $389 Million
Q1 2024 Oct 01, 2024	SELL	$155.22 - $162.74 $21,420 - $22,458	-138 Reduced 5.19%	2,523 $399 Million
Q4 2023 Oct 18, 2024	SELL	$145.6 - $158.88 $47,611 - $51,953	-327 Reduced 12.29%	2,334 $366 Million
Q3 2023 Oct 18, 2024	BUY	$155.75 - $174.48 $20,091 - $22,507	129 Added 5.55%	2,452 $382 Million
Q3 2023 Oct 02, 2024	SELL	$155.75 - $174.48 $361,807 - $405,317	-2,323 Closed	0 $0
Q1 2023 Oct 02, 2024	SELL	$151.05 - $180.26 $51,054 - $60,927	-338 Reduced 12.7%	2,323 $360 Million
Q4 2022 Oct 18, 2024	SELL	$160.2 - $179.79 $1,762 - $1,977	-11 Reduced 0.47%	2,323 $410 Million
Q3 2022 Oct 18, 2024	SELL	$161.33 - $179.52 $8,711 - $9,694	-54 Reduced 2.22%	2,373 $388 Million
Q2 2022 Oct 18, 2024	BUY	$168.19 - $186.01 $6,895 - $7,626	41 Added 1.72%	2,427 $431 Million
Q1 2022 Oct 18, 2024	BUY	$158.14 - $179.59 $8,539 - $9,697	54 Added 2.32%	2,386 $423 Million
Q4 2021 Oct 18, 2024	SELL	$155.93 - $173.01 $311 - $346	-2 Reduced 0.09%	2,332 $399 Million
Q2 2021 Oct 18, 2024	BUY	$159.48 - $171.07 $16,266 - $17,449	102 Added 4.57%	2,332 $384 Million
Q1 2021 Oct 02, 2024	BUY	$153.07 - $170.48 $341,346 - $380,170	2,230 New	2,230 $367 Million
Q4 2020 Oct 18, 2024	SELL	$137.11 - $157.38 $14,259 - $16,367	-104 Reduced 4.46%	2,230 $351 Million
Q4 2020 Oct 02, 2024	SELL	$137.11 - $157.38 $347,573 - $398,958	-2,535 Closed	0 $0
Q3 2020 Oct 02, 2024	SELL	$140.38 - $153.83 $17,687 - $19,382	-126 Reduced 4.74%	2,535 $377 Million
Q2 2020 Oct 18, 2024	SELL	$128.81 - $155.51 $128 - $155	-1 Reduced 0.04%	2,535 $356 Million
Q1 2020 Oct 18, 2024	SELL	$111.14 - $153.99 $16,559 - $22,944	-149 Reduced 5.55%	2,536 $333 Million
Q4 2019 Oct 18, 2024	BUY	$127.5 - $146.44 $44,752 - $51,400	351 Added 15.04%	2,685 $392 Million
Q4 2019 Oct 02, 2024	SELL	$127.5 - $146.44 $347,055 - $398,609	-2,722 Closed	0 $0
Q3 2019 Oct 02, 2024	BUY	$126.95 - $142.14 $139,264 - $155,927	1,097 Added 67.51%	2,722 $352 Million
Q2 2019 Oct 02, 2024	SELL	$131.15 - $144.24 $6,032 - $6,635	-46 Reduced 2.75%	1,625 $226 Million
Q1 2019 Oct 02, 2024	SELL	$125.72 - $139.79 $124,462 - $138,392	-990 Reduced 37.2%	1,671 $234 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.

Account

Cannon Financial Strategists, Inc. Johnson & Johnson Transaction History